Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Feuring

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Kidney International|April 12, 2000
Specific nongenomic actions of aldosteroneE Falkenstein, M Christ, M Feuring, et al.
Platelets|February 4, 2010
The PFA-100R cannot detect blood group-dependent inhibition of platelet function by eptifibatide or abciximab at therapeutic plasma concentrationsM Feuring, A Ruf, A Schultz, et al.
Platelets|October 27, 2009
Circadian variation of platelet function measured with the PFA-100M Feuring, M Wehling, A Ruf, et al.
Deutsche Medizinische Wochenschrift (1946)|August 5, 1999
[New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies]C Buske, M Feuring-Buske, M Unterhalt, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Monoclonal antibody therapy for B cell non-Hodgkin's lymphomas: emerging concepts of a tumour-targeted strategyC Buske, M Feuring-Buske, M Unterhalt, et al.
Annals of Hematology|June 2, 2000
Recent advances in antigen-targeted therapy in non-Hodgkin's lymphomaM Feuring-Buske, C Buske, M Unterhalt, et al.
MMW Fortschritte Der Medizin|August 3, 2007
[Nonsymptomatic leukocytosis]D Sauter, K Spiekermann, M Feuring-Buske, et al.
MMW Fortschritte Der Medizin|February 5, 2002
[Drug therapy in the old age. Drug effects in the elderly]C U Vogel, A Peiter, M Feuring, et al.
Experimental Hematology|January 9, 2001
Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cellsM Feuring-Buske, A Frankel, B Gerhard, et al.
Der Internist|July 27, 1999
[Beta-blockers. Value in cardiovascular diseases]M Feuring, B M Schmidt, M Christ, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Kidney International|April 12, 2000
Specific nongenomic actions of aldosteroneE Falkenstein, M Christ, M Feuring, et al.
Platelets|February 4, 2010
The PFA-100R cannot detect blood group-dependent inhibition of platelet function by eptifibatide or abciximab at therapeutic plasma concentrationsM Feuring, A Ruf, A Schultz, et al.
Platelets|October 27, 2009
Circadian variation of platelet function measured with the PFA-100M Feuring, M Wehling, A Ruf, et al.
Deutsche Medizinische Wochenschrift (1946)|August 5, 1999
[New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies]C Buske, M Feuring-Buske, M Unterhalt, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Monoclonal antibody therapy for B cell non-Hodgkin's lymphomas: emerging concepts of a tumour-targeted strategyC Buske, M Feuring-Buske, M Unterhalt, et al.
Annals of Hematology|June 2, 2000
Recent advances in antigen-targeted therapy in non-Hodgkin's lymphomaM Feuring-Buske, C Buske, M Unterhalt, et al.
MMW Fortschritte Der Medizin|August 3, 2007
[Nonsymptomatic leukocytosis]D Sauter, K Spiekermann, M Feuring-Buske, et al.
MMW Fortschritte Der Medizin|February 5, 2002
[Drug therapy in the old age. Drug effects in the elderly]C U Vogel, A Peiter, M Feuring, et al.
Experimental Hematology|January 9, 2001
Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cellsM Feuring-Buske, A Frankel, B Gerhard, et al.
Der Internist|July 27, 1999
[Beta-blockers. Value in cardiovascular diseases]M Feuring, B M Schmidt, M Christ, et al.
Pageof 8